When out-of-pocket drug costs rise, patients with common neurological disorders are more likely to forgo their medication, a U.S. study suggests. Private insurance claims data show patients with Alzheimer’s disease, Parkinson’s disease and peripheral neuropathy were more likely to cut back on prescription medications when out-of-pocket costs were high, researchers report in Neurology.